The zebrafish embryo as a model for assessing off-target drug effects.
Strähle, Uwe
The zebrafish embryo as a model for assessing off-target drug effects. [electronic resource] - Disease models & mechanisms - 689-92 p. digital
Publication Type: Journal Article
1754-8411
10.1242/dmm.006312 doi
Animals
Benzothiazoles--pharmacology
Cholinesterase Inhibitors--pharmacology
DNA-Binding Proteins--antagonists & inhibitors
Drug-Related Side Effects and Adverse Reactions
Embryo, Nonmammalian--drug effects
Humans
Models, Animal
Nuclear Proteins--antagonists & inhibitors
Pyrazoles--pharmacology
Pyrimidines--pharmacology
Toluene--analogs & derivatives
Tumor Protein p73
Tumor Suppressor Protein p53--antagonists & inhibitors
Tumor Suppressor Proteins--antagonists & inhibitors
Zebrafish--embryology
The zebrafish embryo as a model for assessing off-target drug effects. [electronic resource] - Disease models & mechanisms - 689-92 p. digital
Publication Type: Journal Article
1754-8411
10.1242/dmm.006312 doi
Animals
Benzothiazoles--pharmacology
Cholinesterase Inhibitors--pharmacology
DNA-Binding Proteins--antagonists & inhibitors
Drug-Related Side Effects and Adverse Reactions
Embryo, Nonmammalian--drug effects
Humans
Models, Animal
Nuclear Proteins--antagonists & inhibitors
Pyrazoles--pharmacology
Pyrimidines--pharmacology
Toluene--analogs & derivatives
Tumor Protein p73
Tumor Suppressor Protein p53--antagonists & inhibitors
Tumor Suppressor Proteins--antagonists & inhibitors
Zebrafish--embryology